Global Proton Pump Inhibitors Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Gastroesophageal Reflux Disease (GERD)

Pooja salve

Global Proton Pump Inhibitors Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Gastroesophageal Reflux Disease (GERD)

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 2.9 billion in 2020 and is expected to exhibit a CAGR of 4.30% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

Proton pump inhibitors (PPIs) are a class of drugs used to reduce the production of stomach acid. They are primarily prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders. PPIs work by inhibiting the enzyme responsible for the final step in acid production, thereby providing relief from symptoms such as heartburn and acid regurgitation.

The advantages of PPIs over other acid-suppressing drugs include their long-lasting effects, high efficacy rates, and ability to provide rapid and effective relief from symptoms associated with GERD. These factors have contributed to the growing demand for PPIs globally.

B) Market Key Trends:

One key trend in the global Proton Pump Inhibitors Market is the increasing prevalence of gastroesophageal reflux disease (GERD). GERD is a chronic condition that affects millions of people worldwide. It occurs when stomach acid frequently flows back into the esophagus, causing inflammation and damage to the lining of the esophagus. Factors such as obesity, certain medications, and hiatal hernia contribute to the development of GERD.

As the prevalence of GERD continues to rise, the demand for PPIs is also increasing. According to a study published in Gastroenterology, the prevalence of GERD in the United States increased from 10.1% in 1995 to 19.8% in 2009. This trend is expected to drive the growth of the Proton Pump Inhibitors Market in the coming years.

C) PEST Analysis:

Political: Proton pump inhibitors are prescription drugs that are regulated by government agencies such as the Food and Drug Administration (FDA). The approval process for new PPIs involves rigorous testing and evaluation to ensure their safety and efficacy.

Economic: The global Proton Pump Inhibitors Market is driven by the increasing healthcare expenditure and rising prevalence of GERD worldwide. The growing demand for PPIs has created opportunities for pharmaceutical companies to introduce new products in the market.

Social: Lifestyle changes such as unhealthy dietary habits, obesity, smoking, and alcohol consumption contribute to the development of GERD. The awareness about the importance of managing GERD symptoms has increased among the general population, which has fueled the demand for PPIs.

Technological: Advances in technology have led to the development of innovative drug delivery systems for PPIs. For instance, some companies are exploring the use of nanoparticles for targeted drug delivery to improve the effectiveness of PPIs in reducing acid production.

D) Key Takeaways:

1. Market Size: The global Proton Pump Inhibitors Market is expected to witness high growth, exhibiting a CAGR of 4.30% over the forecast period. This growth can be attributed to the increasing prevalence of GERD and the advantages offered by PPIs in providing relief from acid-related disorders.

2. Regional Analysis: North America is expected to dominate the Proton Pump Inhibitors Market due to the high prevalence of GERD in the region and favorable reimbursement policies. Europe is also expected to contribute significantly to market growth, driven by the presence of key players and increasing research and development activities.

3. Key Players: AstraZeneca PLC, Bayer AG, Pfizer Inc., Cadila Pharmaceuticals Limited, and Eisai Pharmaceuticals India Pvt. Ltd are some of the key players operating in the global Proton Pump Inhibitors Market. These companies focus on strategic collaborations, product launches, and acquisitions to strengthen their market position.

In conclusion, the global Proton Pump Inhibitors Market is expected to witness significant growth over the forecast period. The increasing prevalence of GERD and the advantages offered by PPIs are driving the demand for these drugs. However, stringent government regulations and the availability of generic alternatives may hinder market growth to some extent. Nonetheless, key players are focused on innovation and expanding their product portfolios to capitalize on the growing market opportunities.

Pooja salve

Proton Pump Inhibitors is fastest growing segment fueling the growth of Proton Pump Inhibitors Market

naufan 2023-12-14

They provide effective relief from heartburn and acid reflux by blocking the action of gastric acid pumps in the stomach wall. The proton pump inhibitors market is estimated to be valued at US$ 3. Segment Analysis The global Proton Pump Inhibitors market is dominated by the omeprazole sub-segment. Omeprazole accounts for over 30% of the global market share owing to its high efficacy in treating conditions like acid reflux and peptic ulcers. 3% over the forecast period, due to increasing prevalence of acid reflux diseases and peptic ulcers.

Proton Pump Inhibitors Market is Estimated to Witness High Growth Owing to Increase in Gastrointestinal Problems

Purvaja 2024-02-07

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. Rise in the risk factors that cause gastrointestinal problems such as smoking, excess alcohol consumption and use of anti-inflammatory drugs are driving the growth of the proton pump inhibitors market. SWOT Analysis Strength: Proton pump inhibitors have gained wide acceptance for use in treating acid-related gastrointestinal disorders owing to their effectiveness. Key Takeaways The Global Proton Pump Inhibitors Market Share is expected to witness high growth over the forecast period. The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. The key players operating in the proton pump inhibitors market are Horizon Therapeutics plc, Ammonett Pharma LLC, Medison Pharma Ltd.

Proton Pump Inhibitors is Fueling the Growth of Global Proton Pump Inhibitors Market

Poonam 2023-11-29

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. They are commonly used for conditions like acid reflux, ulcers and heartburn. New product launches by key players with formulations enabling once-a-day dosing have further boosted the adoption of proton pump inhibitors for management of acid reflux and ulcers. Segment Analysis The global proton pump inhibitors market is dominated by the omeprazole sub-segment owing to its significant popularity as an effective treatment option for acid reflux and heartburn. Regional analysis North America currently dominates the global proton pump inhibitors market due to high awareness levels about acid reflux diseases and rising obese population.

Proton Pump Inhibitors Market - Global Outlook and Forecast 2021-2027

sanavi desai 2021-08-26

Proton Pump Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Proton Pump Inhibitors Market Sales, 2016-2021, 2022-2027, (M Units) Global top five Proton Pump Inhibitors companies in 2020 (%)The global Proton Pump Inhibitors market was valued at 13180 million in 2020 and is projected to reach US$ 11640 million by 2027, at a CAGR of -3.1% during the forecast period.We Surveyed the Proton Pump Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6548508/global-proton-pump-inhibitors-2021-2027-594Total Market by Segment:Global Proton Pump Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Type, 2020 (%)DexlansoprazoleEsomeprazoleLansoprazoleOmeprazolePantoprazoleRabeprazoleGlobal Proton Pump Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Application, 2020 (%)Hospital PharmacyRetail PharmacyOthersGlobal Proton Pump Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)Global Proton Pump Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)North AmericaUSCanadaMexicoEuropeGermanyFranceU.K.ItalyRussiaNordic CountriesBeneluxRest of EuropeAsiaChinaJapanSouth KoreaSoutheast AsiaIndiaRest of AsiaSouth AmericaBrazilArgentinaRest of South AmericaMiddle East & AfricaTurkeyIsraelSaudi ArabiaUAERest of Middle East & AfricaCompetitor AnalysisThe report also provides analysis of leading market participants including:Key companies Proton Pump Inhibitors revenues in global market, 2016-2021 (Estimated), ($ millions)Key companies Proton Pump Inhibitors revenues share in global market, 2020 (%)Key companies Proton Pump Inhibitors sales in global market, 2016-2021 (Estimated), (M Units)Key companies Proton Pump Inhibitors sales share in global market, 2020 (%)Further, the report presents profiles of competitors in the market, key players include:TakedaPfizerAstraZenecaBayerSun PharmaTevaEisai Co.MylanAOSAIKANG PharmaLuoxin PharmaLIVZONEastchina PharmaReasons to Purchase Our Research Report:1.

Analyzing the outlook of the market with the recent trends and SWOT analysis2.

Market dynamics scenario, along with growth opportunities of the market in the years to come3.

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.

Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.

Market value (USD Million) and volume (Units Million) data for each segment and sub-segment6.

Proton Pump Inhibitors Market: Increasing Prevalence of Gastroesophageal Reflux Disease Driving Growth

Gauri Cmi 2023-10-10

The global proton pump inhibitors market is estimated to be valued at US$2. The growing need to manage GERD and other acid-related disorders is driving the demand for proton pump inhibitors globally. The bargaining power of buyers in the proton pump inhibitors market is expected to be moderate. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the proton pump inhibitors market. In conclusion, the proton pump inhibitors market is expected to witness substantial growth due to increasing prevalence of acid-related disorders and a growing geriatric population.

Global Proton Pump Inhibitors Market to be Driven by Rise in the Prevalence of Gastrointestinal Disorders in the Forecast Period of 2022-2027

Expert Market Research 2022-02-17

The new report by Expert Market Research titled, ‘Global Proton Pump Inhibitors Market Report and Forecast 2022-2027’, gives in-depth analysis of the global proton pump inhibitors market, assessing the market based on its segments like drug type and major regions. Get a Free Sample Report with Table of Contents: https://www. About Us:Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. comToll Free Number: US +1-415-325-5166 | UK +44-702-402-5790Address: 30 North Gould Street, Sheridan, WY 82801, USACity: SheridanState: WyomingCountry: United StatesWebsite: https://www. comRead More Reports:Global Critical Care Antiarrhythmic Drugs Market Outlook: https://www.

WHO TO FOLLOW